Search

Lorraine Spector

Examiner (ID: 17600, Phone: (571)272-0893 , Office: P/1647 )

Most Active Art Unit
1647
Art Unit(s)
1647, STIC, 1646, 1812
Total Applications
788
Issued Applications
338
Pending Applications
71
Abandoned Applications
379

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 663663 [patent_doc_number] => 07101981 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-05 [patent_title] => 'Bovine growth hormone recombinantly produced in E. coli ' [patent_app_type] => utility [patent_app_number] => 08/487312 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5020 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/101/07101981.pdf [firstpage_image] =>[orig_patent_app_number] => 08487312 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/487312
Bovine growth hormone recombinantly produced in E. coli Jun 6, 1995 Issued
Array ( [id] => 266931 [patent_doc_number] => 07566455 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-07-28 [patent_title] => 'E6AP-binding proteins' [patent_app_type] => utility [patent_app_number] => 08/484878 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 30594 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/566/07566455.pdf [firstpage_image] =>[orig_patent_app_number] => 08484878 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/484878
E6AP-binding proteins Jun 6, 1995 Issued
Array ( [id] => 3929546 [patent_doc_number] => 05877285 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Mammalian thymokine having leukocyte chemotactic activity, and fragments thereof' [patent_app_type] => 1 [patent_app_number] => 8/472604 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25392 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/877/05877285.pdf [firstpage_image] =>[orig_patent_app_number] => 472604 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/472604
Mammalian thymokine having leukocyte chemotactic activity, and fragments thereof Jun 6, 1995 Issued
Array ( [id] => 3935070 [patent_doc_number] => 05989537 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Methods for stimulating granulocyte/macrophage lineage using thrombopoietin' [patent_app_type] => 1 [patent_app_number] => 8/484257 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 27093 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989537.pdf [firstpage_image] =>[orig_patent_app_number] => 484257 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/484257
Methods for stimulating granulocyte/macrophage lineage using thrombopoietin Jun 6, 1995 Issued
Array ( [id] => 303728 [patent_doc_number] => 07534867 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-05-19 [patent_title] => 'Purified mammalian Flt3 ligands; agonists; antagonists' [patent_app_type] => utility [patent_app_number] => 08/484882 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25946 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/534/07534867.pdf [firstpage_image] =>[orig_patent_app_number] => 08484882 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/484882
Purified mammalian Flt3 ligands; agonists; antagonists Jun 6, 1995 Issued
Array ( [id] => 299733 [patent_doc_number] => 07537932 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-05-26 [patent_title] => 'Antibodies that bind purified mammalian FLT3 ligands' [patent_app_type] => utility [patent_app_number] => 08/472168 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25877 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/537/07537932.pdf [firstpage_image] =>[orig_patent_app_number] => 08472168 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/472168
Antibodies that bind purified mammalian FLT3 ligands Jun 6, 1995 Issued
Array ( [id] => 1125510 [patent_doc_number] => 06790439 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-14 [patent_title] => 'Thrombopoietin compositions' [patent_app_type] => B1 [patent_app_number] => 08/486451 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4405 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/790/06790439.pdf [firstpage_image] =>[orig_patent_app_number] => 08486451 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/486451
Thrombopoietin compositions Jun 6, 1995 Issued
Array ( [id] => 1053082 [patent_doc_number] => 06858409 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-22 [patent_title] => 'Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors' [patent_app_type] => utility [patent_app_number] => 08/482283 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 24 [patent_no_of_words] => 18537 [patent_no_of_claims] => 105 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 237 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/858/06858409.pdf [firstpage_image] =>[orig_patent_app_number] => 08482283 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/482283
Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors Jun 6, 1995 Issued
Array ( [id] => 4404577 [patent_doc_number] => 06309640 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)' [patent_app_type] => 1 [patent_app_number] => 8/472753 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 14270 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/309/06309640.pdf [firstpage_image] =>[orig_patent_app_number] => 472753 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/472753
Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay) Jun 6, 1995 Issued
Array ( [id] => 4265215 [patent_doc_number] => 06245329 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Method of inducing calcium flux in cells using mammalian thymokine protein' [patent_app_type] => 1 [patent_app_number] => 8/477537 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26157 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245329.pdf [firstpage_image] =>[orig_patent_app_number] => 477537 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/477537
Method of inducing calcium flux in cells using mammalian thymokine protein Jun 6, 1995 Issued
08/475049 RECOMBINANT MATERIALS FOR PRODUCTION OF SINGLE-CHAIN GLYCOPROTEIN HORMONES Jun 6, 1995 Abandoned
Array ( [id] => 1009122 [patent_doc_number] => 06899882 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-31 [patent_title] => 'Endothelial cell growth factor methods of isolation and expression' [patent_app_type] => utility [patent_app_number] => 08/473276 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 27 [patent_no_of_words] => 16063 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/899/06899882.pdf [firstpage_image] =>[orig_patent_app_number] => 08473276 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/473276
Endothelial cell growth factor methods of isolation and expression Jun 5, 1995 Issued
Array ( [id] => 3893608 [patent_doc_number] => 05750371 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Water-soluble mutein of FGF receptor, DNA and production thereof' [patent_app_type] => 1 [patent_app_number] => 8/471570 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 11020 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750371.pdf [firstpage_image] =>[orig_patent_app_number] => 471570 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/471570
Water-soluble mutein of FGF receptor, DNA and production thereof Jun 5, 1995 Issued
Array ( [id] => 1327662 [patent_doc_number] => 06599873 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-29 [patent_title] => 'Interleukin-1 inhibitors, compositions, and methods of treatment' [patent_app_type] => B1 [patent_app_number] => 08/468425 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 26 [patent_no_of_words] => 15241 [patent_no_of_claims] => 296 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/599/06599873.pdf [firstpage_image] =>[orig_patent_app_number] => 08468425 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/468425
Interleukin-1 inhibitors, compositions, and methods of treatment Jun 5, 1995 Issued
Array ( [id] => 3936233 [patent_doc_number] => 05981265 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Methods for regulating MEKK protein activity' [patent_app_type] => 1 [patent_app_number] => 8/461146 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 40 [patent_no_of_words] => 46445 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981265.pdf [firstpage_image] =>[orig_patent_app_number] => 461146 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/461146
Methods for regulating MEKK protein activity Jun 4, 1995 Issued
08/463222 PRODUCTION OF HUMAN PARATHYROID HORMONE FROM MICROORGANISMS Jun 4, 1995 Abandoned
Array ( [id] => 4129596 [patent_doc_number] => 06146852 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Production of human parathyroid hormone from microorganisms' [patent_app_type] => 1 [patent_app_number] => 8/461436 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 24 [patent_no_of_words] => 13369 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/146/06146852.pdf [firstpage_image] =>[orig_patent_app_number] => 461436 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/461436
Production of human parathyroid hormone from microorganisms Jun 4, 1995 Issued
Array ( [id] => 3811108 [patent_doc_number] => 05770209 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Acceleration of wound healing using connective tissue growth factor' [patent_app_type] => 1 [patent_app_number] => 8/459717 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 18629 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770209.pdf [firstpage_image] =>[orig_patent_app_number] => 459717 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/459717
Acceleration of wound healing using connective tissue growth factor Jun 1, 1995 Issued
Array ( [id] => 3730252 [patent_doc_number] => 05670625 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Elk ligand fusion proteins' [patent_app_type] => 1 [patent_app_number] => 8/460741 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15746 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670625.pdf [firstpage_image] =>[orig_patent_app_number] => 460741 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/460741
Elk ligand fusion proteins Jun 1, 1995 Issued
Array ( [id] => 4045377 [patent_doc_number] => 05874539 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Antibodies to nuclear matrix proteins' [patent_app_type] => 1 [patent_app_number] => 8/459023 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 14039 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 280 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874539.pdf [firstpage_image] =>[orig_patent_app_number] => 459023 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/459023
Antibodies to nuclear matrix proteins Jun 1, 1995 Issued
Menu